Stock Events

Stock Events

Larimar Therapeutics (LRMR) Q2 2026 Earnings

14MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.61

-0.51

-0.41

-0.31

Details

Expected EPS

-0.534548

Actual EPS

-0.31

Surprise EPS

0.22

Surprise Percent

+42.01%

Description

Larimar Therapeutics (LRMR) has reported earnings of -0.31 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.